COVID‐19 patients showed an increase in the serum PD‐L1 level (sPD‐L1) at aCOVID time compared with HD (145 IQR 60–90 vs. 55 IQR 52–69 ng/mL, respectively; p < .0001). This evidence concerns the gene SPDL1 and COVID-19.